Cocrystal Pharma Ownership 2024 | Who Owns Cocrystal Pharma Now?


OverviewRevenueFinancialsChart

Institutional Ownership

166.15%

Insider Ownership

30.03%

Retail Ownership

-96.18%

Institutional Holders

22.00

Cocrystal Pharma Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VANGUARD GROUP INC4.57%-271,445--540,176,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC2.02%0.00%119,8285,8005.09%238,000Mar 31, 2023
BLACKROCK INC.1.25%-74,063--147,385,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC1.17%-69,534--137,677,000Mar 31, 2023
SABBY MANAGEMENT, LLC1.11%0.11%66,172-354,538-84.27%131,682,000Mar 31, 2023
MORGAN STANLEY0.75%-44,694--88,941,000Mar 31, 2023
STATE STREET CORP0.41%-24,443--48,397,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.35%-20,72820,728100.00%41,041,000Mar 31, 2023
PARALLEL ADVISORS, LLC0.26%0.00%15,228--30,304,000Mar 31, 2023
NORTHERN TRUST CORP0.21%-12,207--24,292,000Mar 31, 2023
BANK OF AMERICA CORP /DE/0.15%-8,975-16-0.18%17,860,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.15%0.00%8,6513,80478.48%17,000Mar 31, 2023
UBS GROUP AG0.03%-1,992-3,023-60.28%3,964,000Mar 31, 2023
CLEAN YIELD GROUP0.01%0.00%418--832,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-8611.18%172,000Mar 31, 2023
NVWM, LLC0.00%0.00%84--167,000Mar 31, 2023
ARCHER INVESTMENT CORP0.00%0.00%84--167,000Mar 31, 2023
FMR LLC0.00%-44100.00%8,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.--22100.00%4,000Mar 31, 2023
JPMORGAN CHASE & CO----260-100.00%-Mar 31, 2023

Cocrystal Pharma's largest institutional shareholder is VANGUARD GROUP INC, holding 4.57% of the company's total share outstanding, currently valued at $540.18M. The top 10 institutional shareholders own together 12.10% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SABBY MANAGEMENT, LLC1.11%0.11%66,172-354,538-84.27%131,682,000Mar 31, 2023
PARALLEL ADVISORS, LLC0.26%0.00%15,228--30,304,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.15%0.00%8,6513,80478.48%17,000Mar 31, 2023
CLEAN YIELD GROUP0.01%0.00%418--832,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC2.02%0.00%119,8285,8005.09%238,000Mar 31, 2023
ARCHER INVESTMENT CORP0.00%0.00%84--167,000Mar 31, 2023
NVWM, LLC0.00%0.00%84--167,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC1.17%-69,534--137,677,000Mar 31, 2023
VANGUARD GROUP INC4.57%-271,445--540,176,000Mar 31, 2023
MORGAN STANLEY0.75%-44,694--88,941,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.35%-20,72820,728100.00%41,041,000Mar 31, 2023
NORTHERN TRUST CORP0.21%-12,207--24,292,000Mar 31, 2023
BLACKROCK INC.1.25%-74,063--147,385,000Mar 31, 2023
STATE STREET CORP0.41%-24,443--48,397,000Mar 31, 2023
BANK OF AMERICA CORP /DE/0.15%-8,975-16-0.18%17,860,000Mar 31, 2023
UBS GROUP AG0.03%-1,992-3,023-60.28%3,964,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-8611.18%172,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.--22100.00%4,000Mar 31, 2023
FMR LLC0.00%-44100.00%8,000Mar 31, 2023
NEWEDGE ADVISORS, LLC----18-100.00%-Mar 31, 2023

The largest Cocrystal Pharma shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 66.17K shares of Cocrystal Pharma (COCP), representing 0.11% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.35%-20,72820,728100.00%41,041,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC2.02%0.00%119,8285,8005.09%238,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.15%0.00%8,6513,80478.48%17,000Mar 31, 2023
FMR LLC0.00%-44100.00%8,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.--22100.00%4,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-8611.18%172,000Mar 31, 2023
STATE STREET CORP0.41%-24,443--48,397,000Mar 31, 2023
BLACKROCK INC.1.25%-74,063--147,385,000Mar 31, 2023
NORTHERN TRUST CORP0.21%-12,207--24,292,000Mar 31, 2023
MORGAN STANLEY0.75%-44,694--88,941,000Mar 31, 2023
VANGUARD GROUP INC4.57%-271,445--540,176,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC1.17%-69,534--137,677,000Mar 31, 2023
NVWM, LLC0.00%0.00%84--167,000Mar 31, 2023
ARCHER INVESTMENT CORP0.00%0.00%84--167,000Mar 31, 2023
CLEAN YIELD GROUP0.01%0.00%418--832,000Mar 31, 2023
PARALLEL ADVISORS, LLC0.26%0.00%15,228--30,304,000Mar 31, 2023
BANK OF AMERICA CORP /DE/0.15%-8,975-16-0.18%17,860,000Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.----18-100.00%-Mar 31, 2023
NEWEDGE ADVISORS, LLC----18-100.00%-Mar 31, 2023
JPMORGAN CHASE & CO----260-100.00%-Mar 31, 2023

As of Mar 31 2023, Cocrystal Pharma's largest institutional buyer is SUSQUEHANNA INTERNATIONAL GROUP, LLP. The company purchased 20.73K stocks of COCP, valued at $41.04M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SABBY MANAGEMENT, LLC1.11%0.11%66,172-354,538-84.27%131,682,000Mar 31, 2023
UBS GROUP AG0.03%-1,992-3,023-60.28%3,964,000Mar 31, 2023
JPMORGAN CHASE & CO----260-100.00%-Mar 31, 2023
NEWEDGE ADVISORS, LLC----18-100.00%-Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.----18-100.00%-Mar 31, 2023
BANK OF AMERICA CORP /DE/0.15%-8,975-16-0.18%17,860,000Mar 31, 2023
PARALLEL ADVISORS, LLC0.26%0.00%15,228--30,304,000Mar 31, 2023
CLEAN YIELD GROUP0.01%0.00%418--832,000Mar 31, 2023
ARCHER INVESTMENT CORP0.00%0.00%84--167,000Mar 31, 2023
NVWM, LLC0.00%0.00%84--167,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC1.17%-69,534--137,677,000Mar 31, 2023
VANGUARD GROUP INC4.57%-271,445--540,176,000Mar 31, 2023
MORGAN STANLEY0.75%-44,694--88,941,000Mar 31, 2023
NORTHERN TRUST CORP0.21%-12,207--24,292,000Mar 31, 2023
BLACKROCK INC.1.25%-74,063--147,385,000Mar 31, 2023
STATE STREET CORP0.41%-24,443--48,397,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-8611.18%172,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.--22100.00%4,000Mar 31, 2023
FMR LLC0.00%-44100.00%8,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.15%0.00%8,6513,80478.48%17,000Mar 31, 2023

As of Mar 31 2023, Cocrystal Pharma's biggest institutional seller is SABBY MANAGEMENT, LLC. The company sold -0.35M shares of COCP, valued at $131.68M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.35%-20,72820,728100.00%41,041,000Mar 31, 2023
FMR LLC0.00%-44100.00%8,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.--22100.00%4,000Mar 31, 2023

Cocrystal Pharma's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 20.73K shares, valued at $41.04M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO----260-100.00%-Mar 31, 2023
NEWEDGE ADVISORS, LLC----18-100.00%-Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.----18-100.00%-Mar 31, 2023

Cocrystal Pharma's largest sold out institutional shareholder by shares sold is JPMORGAN CHASE & CO, sold -0.26K shares, valued at -, as of undefined.

Cocrystal Pharma Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
WASATCH FUNDS TRUST0.19%1,791,443--Mar 31, 2024
Vericimetry Funds0.12%12,350--Dec 31, 2023
VANGUARD INDEX FUNDS0.01%3,137,666--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%772,698--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%90,909--Dec 31, 2023
SCHWAB CAPITAL TRUST0.00%39,234--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%344,80176,72128.62%Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%7,576--Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%158,458--Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%4,979--Jan 31, 2024
EQ ADVISORS TRUST0.00%854--Dec 31, 2023
Dimensional ETF Trust0.00%308--Jan 31, 2024
iSHARES TRUST0.00%10,077--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%578--Dec 31, 2023

Cocrystal Pharma's largest mutual fund holder by % of total assets is "WASATCH FUNDS TRUST", owning 1.79M shares, compromising 0.19% of its total assets.

Cocrystal Pharma Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Sep, 2222-15.38%
30 Jun, 2226-3.70%
31 Mar, 2227-6.90%
31 Dec, 2129-27.50%
30 Sep, 21402.56%
30 Jun, 213925.81%
31 Mar, 213110.71%
31 Dec, 202821.74%
30 Sep, 202315.00%
30 Jun, 2020-9.09%
31 Mar, 202210.00%
31 Dec, 1920-9.09%
30 Sep, 192229.41%
30 Jun, 1917-19.05%
31 Mar, 192110.53%
31 Dec, 1819-17.39%
30 Sep, 18239.52%
30 Jun, 182190.91%
31 Mar, 1811-

As of 30 Sep 22, 22 institutions are holding Cocrystal Pharma's shares, representing a decrease of -15.38% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Sep, 2213,529,382-4.62%
30 Jun, 2214,185,118-0.96%
31 Mar, 2214,323,170-4.67%
31 Dec, 2115,025,415-1.68%
30 Sep, 2115,282,542-23.52%
30 Jun, 2119,983,541105.34%
31 Mar, 219,731,815-4.28%
31 Dec, 2010,167,026-20.73%
30 Sep, 2012,825,752132.20%
30 Jun, 205,523,64723.05%
31 Mar, 204,489,08228.68%
31 Dec, 193,488,53524.81%
30 Sep, 192,795,1522.44%
30 Jun, 192,728,5893.17%
31 Mar, 192,644,726137.53%
31 Dec, 181,113,446-20.37%
30 Sep, 181,398,2915.45%
30 Jun, 181,326,028620.95%
31 Mar, 18183,928-

Cocrystal Pharma (COCP) has 13.53M shares outstanding as of 30 Sep 22, down -4.62% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Sep, 22166.15%0.54%
30 Jun, 22174.64%0.56%
31 Mar, 22176.34%0.41%
31 Dec, 21207.08%0.58%
30 Sep, 21188.15%0.25%
30 Jun, 21275.42%1.03%
31 Mar, 21163.91%0.36%
31 Dec, 20211.98%0.30%
30 Sep, 20267.41%1.65%
30 Jun, 20127.12%0.76%
31 Mar, 20129.30%1.28%
31 Dec, 19100.48%0.89%
30 Sep, 19106.07%0.99%
30 Jun, 19103.55%0.95%
31 Mar, 19104.61%5.39%
31 Dec, 1844.04%1.40%
30 Sep, 1856.08%1.70%
30 Jun, 1857.41%70.07%
31 Mar, 189.05%-

As of 30 Sep 22, Cocrystal Pharma is held by 166.15% institutional shareholders, representing a 0.54% growth compared to 30 Jun 22.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Sep, 227-
30 Jun, 227-
31 Mar, 227-30.00%
31 Dec, 2110-37.50%
30 Sep, 2116-40.74%
30 Jun, 212742.11%
31 Mar, 211935.71%
31 Dec, 2014-17.65%
30 Sep, 201770.00%
30 Jun, 2010-28.57%
31 Mar, 201455.56%
31 Dec, 19912.50%
30 Sep, 198-
30 Jun, 198-20.00%
31 Mar, 191025.00%
31 Dec, 188-27.27%
30 Sep, 1811-15.38%
30 Jun, 181318.18%
31 Mar, 1811-

7 institutional shareholders have increased their position in COCP stock as of 30 Sep 22 compared to 7 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Sep, 224-42.86%
30 Jun, 227-22.22%
31 Mar, 22950.00%
31 Dec, 216-45.45%
30 Sep, 211183.33%
30 Jun, 21650.00%
31 Mar, 214-42.86%
31 Dec, 207250.00%
30 Sep, 202-
30 Jun, 202-
31 Mar, 202-33.33%
31 Dec, 193-50.00%
30 Sep, 19620.00%
30 Jun, 19525.00%
31 Mar, 194-
31 Dec, 184-42.86%
30 Sep, 187250.00%
30 Jun, 182-
31 Mar, 18--

4 institutional shareholders have reduced their position in COCP stock as of 30 Sep 22 compared to 7 in the previous quarter (a -42.86% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Sep, 2222-15.38%13,529,382-4.62%166.15%0.54%7-4-42.86%
30 Jun, 2226-3.70%14,185,118-0.96%174.64%0.56%7-7-22.22%
31 Mar, 2227-6.90%14,323,170-4.67%176.34%0.41%7-30.00%950.00%
31 Dec, 2129-27.50%15,025,415-1.68%207.08%0.58%10-37.50%6-45.45%
30 Sep, 21402.56%15,282,542-23.52%188.15%0.25%16-40.74%1183.33%
30 Jun, 213925.81%19,983,541105.34%275.42%1.03%2742.11%650.00%
31 Mar, 213110.71%9,731,815-4.28%163.91%0.36%1935.71%4-42.86%
31 Dec, 202821.74%10,167,026-20.73%211.98%0.30%14-17.65%7250.00%
30 Sep, 202315.00%12,825,752132.20%267.41%1.65%1770.00%2-
30 Jun, 2020-9.09%5,523,64723.05%127.12%0.76%10-28.57%2-
31 Mar, 202210.00%4,489,08228.68%129.30%1.28%1455.56%2-33.33%
31 Dec, 1920-9.09%3,488,53524.81%100.48%0.89%912.50%3-50.00%
30 Sep, 192229.41%2,795,1522.44%106.07%0.99%8-620.00%
30 Jun, 1917-19.05%2,728,5893.17%103.55%0.95%8-20.00%525.00%
31 Mar, 192110.53%2,644,726137.53%104.61%5.39%1025.00%4-
31 Dec, 1819-17.39%1,113,446-20.37%44.04%1.40%8-27.27%4-42.86%
30 Sep, 18239.52%1,398,2915.45%56.08%1.70%11-15.38%7250.00%
30 Jun, 182190.91%1,326,028620.95%57.41%70.07%1318.18%2-
31 Mar, 1811-183,928-9.05%-11---

Cocrystal Pharma Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 06, 2023FROST PHILLIP MD ET ALdirector, 10 percent owner P-PurchaseBuy1,015,229$1.97$2.00M1,319,838

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 06, 2023FROST PHILLIP MD ET ALdirector, 10 percent owner P-PurchaseBuy1,015,229$1.97$2.00M1,319,838

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 27, 2023Hassan Freddirector-Sell---1,015,229

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 20, 2023FROST PHILLIP MD ET ALdirector, 10 percent owner A-AwardBuy19,333$2.67$51.62K19,333
Jul 20, 2023Japour Anthony Jdirector-A-AwardBuy13,567$2.67$36.22K13,567
Jul 20, 2023Martin James Josephofficer Co-CEO and CFOA-AwardBuy30,000$2.67$80.10K30,000
Jul 20, 2023Kornberg Roger D.director-A-AwardBuy24,417$2.67$65.19K24,417
Jul 20, 2023Lee Samofficer President and Co-CEOA-AwardBuy30,000$2.67$80.10K30,000
Jul 20, 2023PFENNIGER RICHARD C JRdirector-A-AwardBuy7,333$2.67$19.58K7,333
Jul 20, 2023Hassan Freddirector-A-AwardBuy7,333$2.67$19.58K7,333
Jul 20, 2023Rubin Steven Ddirector-A-AwardBuy17,233$2.67$46.01K17,233
Apr 27, 2023Hassan Freddirector-Sell---1,015,229
Apr 06, 2023FROST PHILLIP MD ET ALdirector, 10 percent owner P-PurchaseBuy1,015,229$1.97$2.00M1,319,838
Aug 03, 2022Japour Anthony Jdirector A-AwardBuy148,000--148,000
Aug 03, 2022Martin James Josephofficer Co- Interim CEO and CFOA-AwardBuy300,000--300,000
Aug 03, 2022Martin James Josephofficer Co- Interim CEO and CFOA-AwardBuy300,000$0.42$126.00K300,000
Aug 03, 2022PFENNIGER RICHARD C JRdirector A-AwardBuy80,000--80,000
Aug 03, 2022PFENNIGER RICHARD C JRdirector-A-AwardBuy80,000$0.42$33.60K80,000
Aug 03, 2022FROST PHILLIP MD ET ALdirector A-AwardBuy220,000--220,000
Aug 03, 2022FROST PHILLIP MD ET ALdirector-A-AwardBuy220,000$0.42$92.40K220,000
Aug 03, 2022Rubin Steven Ddirector A-AwardBuy188,000--188,000
Aug 03, 2022Rubin Steven Ddirector-A-AwardBuy188,000$0.42$78.96K188,000
Aug 03, 2022Kornberg Roger D.director A-AwardBuy280,000--280,000

The last insider sell of Cocrystal Pharma's stock was made by Hassan Fred on Apr 27 2023, selling - shares at - per share (valued at -). The last insider buy of COCP was made by FROST PHILLIP MD ET AL on Apr 06 2023, buying 1,015,229 shares at $1.97 per share (worth $2.00M).

Cocrystal Pharma Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20238--
Q2 202311100.00%
Q3 20227--
Q3 20218--
Q2 2021-1-
Q4 20201--
Q2 202071700.00%
Q4 20193--
Q2 2019---
Q1 2019---
Q3 20188--
Q2 201852250.00%
Q4 20171--
Q3 201711100.00%
Q2 20171--
Q1 2017---
Q4 2016-1-
Q3 20163--
Q1 20168--
Q4 20154--

8 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Cocrystal Pharma's insiders, as of Q3 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2023---
Q2 20231--
Q3 2022---
Q3 20211--
Q2 2021-1-
Q4 2020---
Q2 2020---
Q4 20193--
Q2 2019---
Q1 2019---
Q3 2018---
Q2 2018---
Q4 2017---
Q3 2017---
Q2 2017---
Q1 2017---
Q4 2016-1-
Q3 20163--
Q1 20168--
Q4 20151--

As of Q3 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cocrystal Pharma's stocks.

Cocrystal Pharma Peer Ownership


TickerCompany
BDRXBiodexa Pharmaceuticals Plc
VRAXVirax Biolabs Group Limited
QNRXQuoin Pharmaceuticals, Ltd.
TPSTTempest Therapeutics, Inc.
MBRXMoleculin Biotech, Inc.
RNXTRenovoRx, Inc.
BWVOnconetix, Inc.
PXMDPaxMedica, Inc. Common Stock
REVBRevelation Biosciences, Inc.
CYCCCyclacel Pharmaceuticals, Inc.
BPTHBio-Path Holdings, Inc.
PULMPulmatrix, Inc.
HILSTharimmune, Inc.
IKNAIkena Oncology, Inc.
ALLRAllarity Therapeutics, Inc.
AKTXAkari Therapeutics, Plc
ONTXTraws Pharma, Inc.
CBIOGyre Therapeutics, Inc.

COCP Ownership FAQ


Cocrystal Pharma is owned by institutional shareholders (166.15%), insiders (30.03%), and public (-96.18%). The largest institutional shareholder of Cocrystal Pharma is VANGUARD GROUP INC (4.57% of total shares) and the top mutual fund owner is WASATCH FUNDS TRUST (0.19% of total shares).

Cocrystal Pharma's major institutional shareholders are VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BLACKROCK INC., GEODE CAPITAL MANAGEMENT, LLC, and SABBY MANAGEMENT, LLC. The top five shareholders own together 10.12% of the company's share outstanding.

As of Sep 2022, there are 22 institutional shareholders of Cocrystal Pharma.

VANGUARD GROUP INC owns 271.44K shares of Cocrystal Pharma, representing 4.57% of the company's total shares outstanding, valued at $540.18M (as of Mar 2023).

As of Mar 2023, RENAISSANCE TECHNOLOGIES LLC holds 119.83K shares of Cocrystal Pharma (COCP), compromising 2.02% of the company, valued at $238K.

BLACKROCK INC is the third largest holder of Cocrystal Pharma. The company owns 74.06K of the company's shares outstanding (worth $147.38M).